Maternal serum levels of total activin-A in first-trimester trisomy 21 pregnancies

被引：12
|
作者：
Spencer, K
Liao, AW
Skentou, H
Ong, CYT
Nicolaides, KH
机构：
[1] Harold Wood Hosp, Dept Clin Biochem, Endocrine Unit, Romford RM3 0BE, Essex, England
[2] Kings Coll Hosp London, Harris Birthright Res Ctr Fetal Med, London SE5 8RX, England
来源：
PRENATAL DIAGNOSIS | 2001年 / 21卷 / 04期
关键词：
prenatal screening; Down syndrome; inhibin; free beta-hCG; PAPP-A;
D O I：
10.1002/pd.53
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
Maternal serum total activin-A concentration was measured in 45 pregnancies affected by trisomy 21 and il 93 control unaffected pregnancies at 10-14 weeks of gestation. In the trisomy 21 pregnancies total activin-A concentration was significantly higher (1.36 MoM of the unaffected pregnancies) and in 16% of cases the level was above the 95th centile of normal. The log(10) SD for the control group and the trisomy 21 group were 0.17 and 0.22. respectively. The median pregnancy associated plasma protein-A (PAPP-A) in this trisomy 21 series was 0.49 and for free beta -hCG was 2.05. In the trisomy group there were significant positive associations between total activin-A and PAPP-A (0.6071) and free beta -hCG (0.4255). The low median difference and the high overlap in values between trisomic and unaffected pregnancies make total activin-A of little practical use in first-trimester screening for trisomy 21. Copyright (C) 2001 John Wiley & Sons, Ltd.
引用
收藏
页码：270 / 273
页数：4
相关论文
共 50 条
  • [21] Screening for trisomy 21 in twin pregnancies in the first trimester:: does chorionicity impact on maternal serum free β-hCG or PAPP-A levels?
    Spencer, K
    PRENATAL DIAGNOSIS, 2001, 21 (09) : 715 - 717
  • [22] First trimester maternal serum concentrations of fetal antigen 2 in normal pregnancies and those affected by trisomy 21
    Price, KM
    Van Lith, JMM
    Silman, R
    Mantingh, A
    Grudzinskas, JG
    HUMAN REPRODUCTION, 1998, 13 (06) : 1706 - 1708
  • [23] FIRST-TRIMESTER MATERNAL SERUM IMMUNOREACTIVE INHIBIN IN CHROMOSOMALLY NORMAL AND ABNORMAL PREGNANCIES
    VANLITH, JMM
    MANTINGH, A
    PRATT, JJ
    OBSTETRICS AND GYNECOLOGY, 1994, 83 (05): : 661 - 664
  • [24] Nasal bone in first-trimester screening for trisomy 21
    Cicero, Simona
    Avgidou, Kyriaki
    Rembouskos, Georgios
    Kagan, Karl Oliver
    Nicolaides, Kypros H.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2006, 195 (01) : 109 - 114
  • [25] Distinctive pattern of first trimester maternal serum biochemical markers in trisomy 22 pregnancies
    Sifakis, S.
    Karkaletsi, M.
    Christopoulou, S.
    Donoghue, J.
    Kaminopetros, P.
    Konstantinidou, T.
    Velissariou, V.
    PRENATAL DIAGNOSIS, 2008, 28 (12) : 1174 - 1176
  • [26] Serum leptin in first-trimester Down syndrome pregnancies
    Hedley, Paula
    Christiansen, Michael
    PRENATAL DIAGNOSIS, 2008, 28 (06) : 475 - 477
  • [27] First-trimester maternal placental protein 13 levels in pregnancies resulting in adverse outcomes
    Cowans, Nicholas J.
    Spencer, Kevin
    Meiri, Hamutal
    PRENATAL DIAGNOSIS, 2008, 28 (02) : 121 - 125
  • [28] Impact of the Maternal Age-Related Risk in First-Trimester Combined Screening for Trisomy 21
    Abele, H.
    Luethgens, K.
    HoopmannA, M.
    Kagan, K. O.
    FETAL DIAGNOSIS AND THERAPY, 2011, 30 (02) : 135 - 140
  • [29] Maternal serum Activin-A and intact hCG in pregnancies complicated by fetal growth restriction
    Fick, A
    McAsey, M
    Fraser, R
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2001, 185 (06) : S240 - S240
  • [30] Application of an individualized nomogram in first-trimester screening for trisomy 21
    Sun, Y.
    Zhang, L.
    Dong, D.
    Li, X.
    Wang, J.
    Yin, C.
    Poon, L. C.
    Tian, J.
    Wu, Q.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2021, 58 (01) : 56 - 66
12345